However, only less than 9,000 patients per year are received with these therapies, currently in Japan.
Hopefully, what should we expect from next generation of antiarrhythmic drugs will be considered.
The selection of devices for heart failure patients is the most important clinical issue for electrophysiologists, especially in proposed high risk patients for sudden cardiac death.
In this symposium, experts from abroad and Japan will discuss in detail the progress in basic as well as clinical cardiac electrophysiology.
The repolarization and depolarization hypotheses are not necessarily mutually exclusive and may indeed be synergistic.
Catheter ablation for Brugada syndrome will be discussed in the other session.
The computer simulation has conventionally been used to generate a single cell action potential model.
For ventricular tachyarrhythmias, cervical vagal nerve stimulation with a sophisticated device, left stellate ganglionectomy, and renal sympathetic denervation with radiofrequency energy are now promising, adjunctive treatment techniques.